Varnavas VC, Kontaras K, Glava C, Maniotis CD, Koutouzis M, Baltogiannis GG, Papalois A, Kolettis TM, Kyriakides ZS. Chronic skeletal muscle ischemia preserves coronary flow in the ischemic rat heart. Am J Physiol Heart Circ Physiol 301: H1229-H1235, 2011. First published July 15, 2011; doi:10.1152/ajpheart.00232.2011.-Chronic skeletal muscle ischemia confers cytoprotection to the ventricular myocardium during infarction, but the underlying mechanisms remain unclear. Although neovascularization in the left ventricular myocardium has been proposed as a possible mechanism, the functional capacity of such vessels has not been studied. We examined the effects of chronic limb ischemia on infarct size, coronary blood flow, and left ventricular function after ischemia-reperfusion. Hindlimb ischemia was induced in 65 Wistar rats by excision of the left femoral artery, whereas 65 rats were sham operated. After 4 wk, myocardial infarction was generated by permanent coronary artery ligation. Infarct size was measured 24 h postligation. Left ventricular function was evaluated in isolated hearts after ischemia-reperfusion, 4 wk after limb ischemia. Neovascularization was assessed by immunohistochemistry, and coronary flow was measured under maximum vasodilatation at different perfusion pressures before and after coronary ligation. Infarct size was smaller after limb ischemia compared with controls (24.4 Ϯ 8.1% vs. 46.2 Ϯ 9.5% of the ventricle and 47.6 Ϯ 8.7% vs. 80.1 Ϯ 9.3% of the ischemic area, respectively). Indexes of left ventricular function at the end of reperfusion (divided by baseline values) were improved after limb ischemia (developed pressure: 0.68 Ϯ 0.06 vs. 0.59 Ϯ 0.05, P ϭ 0.008; maximum ϩdP/dt: 0.70 Ϯ 0.08 vs. 0.59 Ϯ 0.04, P ϭ 0.004; and maximum ϪdP/dt: 0.86 Ϯ 0.14 vs. 0.72 Ϯ 0.10, P ϭ 0.041). Coronary vessel density was markedly higher (P ϭ 0.00021) in limb ischemic rats. In contrast to controls (F ϭ 5.65, P ϭ 0.00182), where coronary flow decreased, it remained unchanged (F ϭ 1.36, P ϭ 0.28) after ligation in limb ischemic rats. In conclusion, chronic hindlimb ischemia decreases infarct size and attenuates left ventricular dysfunction by increasing coronary collateral vessel density and blood flow. chronic limb ischemia; infarct size; left ventricular function ISCHEMIC MYOCARDIAL PRECONDITIONING describes the situation where the ventricular myocardium is rendered more resistant to a prolonged ischemic insult by preceding brief periods of ischemia (22, 23) . In the experimental setting, a further approach of myocardial protection has been observed after short ischemic episodes of peripheral tissues, a process termed remote ischemic preconditioning (2, 14) . Cytoprotection in the heart has been demonstrated after ischemia in a variety of peripheral tissues, such as the mesenterium, kidney, and skeletal muscle (12, 32). Of these, skeletal muscles have attracted considerable scientific interest because they are easily accessible and can be manipulated without major risk in the clinical setting, should this method prove of therapeutic value. Indeed, a number of experimental studies (7, 14, 16 -18, 20) have demonstrated decreased infarct size after coronary artery ligation when preceded by brief ischemic insults of a skeletal muscle.
ISCHEMIC MYOCARDIAL PRECONDITIONING describes the situation where the ventricular myocardium is rendered more resistant to a prolonged ischemic insult by preceding brief periods of ischemia (22, 23) . In the experimental setting, a further approach of myocardial protection has been observed after short ischemic episodes of peripheral tissues, a process termed remote ischemic preconditioning (2, 14) . Cytoprotection in the heart has been demonstrated after ischemia in a variety of peripheral tissues, such as the mesenterium, kidney, and skeletal muscle (12, 32) . Of these, skeletal muscles have attracted considerable scientific interest because they are easily accessible and can be manipulated without major risk in the clinical setting, should this method prove of therapeutic value. Indeed, a number of experimental studies (7, 14, 16 -18, 20) have demonstrated decreased infarct size after coronary artery ligation when preceded by brief ischemic insults of a skeletal muscle.
Chronic skeletal muscle ischemia represents a more exaggerated model of remote preconditioning. Previous studies (11, 27) have established that chronic limb ischemia results in local collateral circulation, aiming at preserving blood supply. This collateral vessel growth is characterized by enlargement of incomplete preexisting anastomoses toward large peripheral arteries (6) . We have previously hypothesized that the stimuli responsible for the development of collateral circulation in the skeletal muscle may act remotely in the ventricular myocardium. This hypothesis was validated in a chronic hindlimb ischemia model in rabbits; in this study (31) , 4-wk skeletal muscle ischemia resulted in significantly smaller infarct sizes after 30 min of regional heart ischemia followed by 3 h of reperfusion. This beneficial effect appeared to be secondary to collateral vessel growth, as evidenced by an ϳ10% increase in subendocardial and intramyocardial noncapillary vessels. However, the importance of neovascularization as a mechanism of myocardial protection after chronic skeletal muscle ischemia cannot be established from this work (31) because the functional capacity of these vessels during regional myocardial ischemia was not investigated.
The purpose of the present study was fourfold. First, we sought to investigate whether the decreased myocardial necrosis, observed previously in limb ischemic animals after myocardial ischemia-reperfusion (I/R), is translated into improved left ventricular (LV) function during the immediate reperfusion period. Second, we examined the functional capacity of neovascularization by measuring coronary flow after regional myocardial ischemia. Third, we aimed to confirm the proangiogenic effects of chronic skeletal muscle ischemia in the rat model. Finally, we further investigated the potential underlying beneficial mechanisms of chronic limb ischemia by examining the previously proposed hypothesis (4, 8, 21, 30, 31) , namely, that chronic skeletal muscle ischemia decreases myocardial necrosis by ameliorating reperfusion injury. To this end, we measured infarct size after coronary artery ligation without reperfusion in animals with and without chronic limb ischemia; comparable infarct sizes in the two groups would validate this hypothesis, whereas decreased myocardial ne-crosis after chronic skeletal muscle ischemia would implicate additional beneficial mechanisms.
MATERIALS AND METHODS
The initial experimental animal cohort comprised 130 Wistar rats (252 Ϯ 23 g). All animals were housed in individual cages in a climate-controlled environment with an artificial 12:12-h light-dark cycle. Access to food and water was unrestricted. All animals received humane care, and the procedures were in accordance with the recommendations of the Declaration of Helsinki. This investigation conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996). The experimental protocol was approved by the Department of Veterinary Medicine and Animal Welfare (Athens, Greece).
Induction of femoral ischemia. Chronic ischemia of the left hindlimb was surgically induced in 65 rats (256 Ϯ 24 g), whereas the remaining 65 rats (255 Ϯ 27 g) were sham operated and served as controls. The induction of hindlimb ischemia was performed as previously described (31) and is briefly summarized below.
Animals were intubated and mechanically ventilated using a rodent ventilator (model 7025, Ugo Basile, Comerio Varese, Italy). Anesthesia was maintained with a mixture of oxygen and 2% isoflurane. After a longitudinal incision in the left thigh, the femoral artery was dissected free along its entire length, including all its major branches, i.e., the inferior epigastrial, deep femoral, lateral circumflex, and superficial epigastric arteries. After the popliteal and saphenous arteries were further dissected distally, the external iliac artery and all major branches of the femoral artery were ligated. Finally, the femoral artery was completely excised from its proximal origin to its distal bifurcation. After the procedure, animals were left to recover under close supervision and care. Prophylactic antibiotics were administered subcutaneously for a total of 5 days postoperatively. Analgesia was administered subcutaneously as required, by evidence of discomfort throughout the study duration. Sham-operated animals received identical anesthesia and antibiotic regimens. At the end of the fourth week, all animals were macroscopically examined for skin necrosis and limb atrophy.
Four weeks after the induction of ischemia (or sham operation), animals were divided into four series of experiments. The first series (n ϭ 20) consisted of the assessment of LV function during I/R in isolated heart preparations. The second series (n ϭ 20) consisted of coronary flow measurements during I/R in isolated heart preparations. In the third series (n ϭ 20) of experiments, histological assessment of coronary neovascularization was performed. Finally, the fourth series (n ϭ 70) consisted of infarct size measurement after the induction of myocardial infarction without reperfusion.
Myocardial infarction generation. Myocardial infarction was generated in vivo as previously described (1, 9) . In brief, animals were intubated and mechanically ventilated as outlined above. Through a left thoracotomy, the pectoralis muscles were dissected, and the thoracic cage was opened with a blunt curved forceps. The pericardium was carefully dissected, the heart was exteriorized, and the left coronary artery was encircled and ligated near its origin with a 6-0 suture placed between the pulmonary artery cone and the left atrial appendage. Following these anatomic landmarks ensures the induction of myocardial infarction of comparable size in all experiments. The incision was closed in three layers, and the remaining air was aspirated from the thorax, allowing the resumption of spontaneous respiration. A six-lead ECG was obtained, and ST elevation in two or more leads was considered proof of induced infarction.
Infarct size measurement. Twenty-four hours after ligation, animals were killed with a lethal dose of potassium chloride (arresting the heart in diastole), and infarct size was determined as previously described (33) . Briefly, the heart was excised and frozen at Ϫ20°C for 1 h; subsequently, it was hand cut into 2-mm slices and incubated in triphenyltetrazolium chloride at a temperature of 37°C for 15 min.
Once the color had been established, slices were fixed in 10% formalin for 20 min. With this method, living tissue is colored red, whereas infarcted tissue retains its pale tan color. Slices were placed on a Plexiglas holder and scanned with a high-resolution scanner (Scanjet 4570c, Hewlett-Packard). Areas of infarcted and noninfarcted myocardium were determined by planimetry of the magnified scanned images using a previously validated software program (Image Tool, University of Texas, San Antonio, TX). Infarct size, expressed as a percentage of the LV cross-sectional area, was defined as the ratio between the infarcted area divided by the total LV area, as follows: infarct size/LV mass (in %) ϭ ⌺ (infarct weight in each slice/total LV weight) ϫ 100.
To exclude differences in infarct size secondary to disparate ischemic areas at risk, we measured ischemic and necrotic areas in a separate set of experiments using a previously utilized method in our laboratory (19) . After anesthesia with ketamine and xylazine, the heart was harvested and mounted on a perfusion apparatus. The coronary ligature was released, and the heart was perfused via the aorta with normal saline at room temperature for 2 min. When all residual blood had been removed from the coronary arteries, the coronary ligature was retightened at the same site, and 5 ml of green fluorescent microspheres (Duke Scientific, Palo Alto, CA), 2-9 m in diameter, suspended in saline, were infused over 5 min. After removal of the right ventricle, hearts were frozen at Ϫ20°C for 24 h and sliced into 2-mm sections from the apex to the base. Slices were incubated in 1% triphenyltetrazolium chloride in isotonic phosphate buffer solution (at 37°C, pH 7.4) for 20 min and immersed in 10% formaldehyde solution for 24 h. Slices were placed between glass plates, and the risk zone, infarcted area, and normal myocardium were identified under ultraviolet light (wavelength: 366 nm) and measured with the use of Image Tool. Volumes of the infarct area and area at risk were expressed in centimeters cubed, and the percent ratio of infarct area/area at risk was calculated.
I/R ex vivo. After animals were anesthesized with a mixture of ketamine and xylazine, a left lateral thoracotomy was performed. The heart was quickly dissected, cannulated through the ascending aorta, and perfused with oxygenated (95% O 2-5% CO2) Krebs-Henseleit buffer (supplemented with 0.001% adenosine) on a Langendorff apparatus (ML870B2 system, AD Instruments, Oxfordshire, UK), as previously delineated (15) . The isolated heart preparation was paced at 300 beats/min and perfused at a constant coronary perfusion pressure of 70 mmHg. A water-filled transducer balloon connected to a pressure transducer was placed into the LV through a left atrial incision. The balloon volume was adjusted to maintain a stable LV end-diastolic pressure of 6 -7 mmHg. The LV pressure signal was continuously recorded and analyzed online by a dedicated software program (Chart 5, version 5.4.2, AD Instruments). Zero-flow global ischemia was induced for 20 min followed by a 45-min reperfusion period.
Assessment of LV function. The following variables were recorded at baseline (steady state for a minimum of 10 min) and at the end of reperfusion: peak systolic pressure, end-diastolic pressure, LV developed pressure (LVDP; defined as peak systolic pressure minus enddiastolic pressure), and the first derivative of LV pressure (maximum ϩdP/dt and ϪdP/dt). They were expressed as the ratio of values at the end of reperfusion divided by baseline values.
Ischemic contracture and hypercontracture were recorded as additional measures of LV function during I/R. We recorded the time point of ischemic contracture, which was defined as a marked, abrupt increase in the minimal value of LV pressure during ischemia. Hypercontracture was expressed as the peak value of LV diastolic pressure during the first 5 min of reperfusion.
Coronary flow in isolated heart preparations. Coronary flow was assessed on a Langendorff apparatus as previously described (10) . Briefly, isolated heart preparations were perfused with oxygenated (95% O2-5% CO2) Krebs-Henseleit buffer (supplemented with 0.001% adenosine to induce maximal coronary vasodilatation). After an ϳ10-min stabilization period, the coronary perfusate was collected at five different perfusion pressures (namely, 60, 80, 100, 120, and 140 mmHg, each of 2-min duration), and the volume was measured. The left coronary artery was then ligated using a 6-0 suture placed between the pulmonary artery cone and the left atrial appendage. Five minutes after ligation, the perfusate collection procedure was repeated at the same perfusion pressures. At the end of the experiment, hearts were weighed; coronary flow was calculated and reported as milliliters per minute per gram. Coronary blood flow analysis included comparisons between groups at baseline conditions and after coronary ligation at various perfusion pressures.
Histological assessment of neovascularization. Four weeks after hindlimb ischemia, animals were killed with intracardiac potassium chloride; hearts were excised, flushed with cold saline, and fixed in 10% buffered formalin solution for 24 h. A central transversal section of each heart was embedded in paraffin, and two tissue sections of 3 m in thickness were obtained and placed on Superfrost Slides (Thermo Fisher Scientific). The first section was stained with hematoxylin and eosin for the initial evaluation, and the second section was stained immunohistochemically with ␣-smooth muscle actin (polyclonal antibody, RB-9010-P, Lab Vision) for the detection of smallsized vessels. Since capillaries and lymphatics lack smooth muscle walls, the use of this method permits the identification of precapillary arterioles (5) . Histological sections were evaluated by a pathologist blinded to treatment assignment.
Blood vessels were determined in the whole histological section using a ϫ40 objective lens and are reported as total number (sum of vessel counts in all fields) and as vessel density (vessel count divided by myocardial area). Vessels of Ͻ50 m in diameter with an obvious lumen stained positive for ␣-smooth muscle actin with at least one layer of smooth muscle were considered as arterioles and were included in the analysis. In contrast, large-sized arteries or venules (the immediate branches of the epicardial coronary network) were excluded.
Statistical analysis. Continuous variables are reported as means Ϯ SD and were compared using Student's t-test for independent variables. Categorical variables were compared with a two-tailed Fisher's exact test. Coronary flow during regional ischemia was evaluated with ANOVA for repeated measures. The effect of different perfusion pressures was examined using the post hoc Newman-Keuls multistage test. Statistical significance was defined at an ␣-level of 0.05.
RESULTS
All animals recovered well after the induction of left hindlimb ischemia. Four weeks after the procedure, signs of severe limb ischemia, namely, skin necrosis and limb atrophy, were present in all animals.
Infarct size after myocardial infarction without reperfusion in vivo. Myocardial infarction was generated in 25 rats with limb ischemia and in 25 control rats. Of these, four animals (2 animals with limb ischemia and 2 sham-operated animals) died during surgical manipulations and were excluded. During the 24-h observation period, five limb ischemic animals (21.7%) and seven sham-operated animals (30.4%) died due to myocardial infarction complications, but this difference failed to reach statistical significance (P ϭ 0.73). Infarct size was significantly (P Ͻ 0.0001) smaller in rats subjected to chronic limb ischemia (25.4 Ϯ 8.1%) than in sham-operated animals (46.2 Ϯ 9.5%). Representative examples are shown in Fig. 1A , and values are shown in Fig. 1B .
In a separate set of experiments of 10 limb ischemic animals and 10 sham-operated animals, the necrotic area was expressed as a percentage of the area at risk. Four animals (3 shamoperated animals and 1 limb ischemic animal, P ϭ 0.58) died during the 24-h postinfarction period and were excluded. The necrotic area was smaller (P Ͻ 0.0001) in limb ischemic animals (47.6 Ϯ 8.7%) than in sham-operated animals (80.1 Ϯ 9.3%). The area at risk (expressed as a percentage of the LV) did not differ between groups (58.9 Ϯ 4.6% vs. 59.4 Ϯ 7.1%, respectively, P ϭ 0.61). Values are shown in Fig. 1B .
LV function after I/R. Ischemic contracture occurred 11.92 Ϯ 3.85 min after ischemia in control hearts and 15.18 Ϯ 1.66 min after ischemia in hearts with prior limb ischemia (P ϭ 0.045; Fig. 2 ). In contrast, the maximal value of diastolic pressure during reperfusion (hypercontracture) did not differ (P ϭ 0.61) between the two groups (limb ischemia: 66.5 Ϯ 13.5 mmHg and control: 69.8 Ϯ 11.8 mmHg).
LV peak systolic pressure at the end of reperfusion exhibited improved (P ϭ 0.018) recovery in the limb ischemia group In contrast to systolic LV function, differences in diastolic function were less pronounced. The recovery of ϪdP/dt was 0.86 Ϯ 0.14 in the limb ischemia group versus 0.72 Ϯ 0.10 in the control group (P ϭ 0.041). However, end-diastolic pressure remained elevated after reperfusion in both groups, displaying a 5.5 Ϯ 2.59-and 4.62 Ϯ 1.11-fold increase of baseline values in the control and limb ischemia groups, respectively (P ϭ 0.39). All values are shown in Fig. 3 .
Coronary flow in isolated heart preparations. Compared with baseline, coronary flow under regional ischemia decreased significantly (F ϭ 5.65, P ϭ 0.00182) in control rats. This decrease was more pronounced under perfusion pressures of 120 and 140 mmHg compared with 60 mmHg. In contrast, coronary flow was maintained (F ϭ 1.36, P ϭ 0.28) in rats with chronic limb ischemia (Fig. 4) . No statistically significant difference was observed in coronary flow baseline values between the two groups at various perfusion pressures. In contrast, under regional ischemia, coronary blood flow was higher (P Ͻ 0.05) at all perfusion pressures examined (Table 1) .
Coronary vessel counts.
The total number of arterioles was higher (P ϭ 0.000034) in limb ischemic rats (78 Ϯ 18.33) compared with control rats (34.88 Ϯ 12.41). Similarly, the vessel density was higher (P ϭ 0.000212) in limb ischemic rats (1.9 Ϯ 0.463) than in control rats (0.97 Ϯ 0.328; Fig. 5 ). The areas of the tissue examined were comparable (P ϭ 0.24) in the sham-operated and limb ischemic groups (37.5 Ϯ 12.5 vs. 45.3 Ϯ 14.8 mm 2 , respectively).
DISCUSSION
The present study demonstrates that chronic (4 wk) severe ischemia in the rat hindlimb results in cytoprotection of the ischemic myocardium, confirming prior observations in the rabbit (31) . Therefore, the beneficial effects of chronic skeletal muscle ischemia on the ventricular myocardium are not specific for a particular species. Although the cardioprotective effects of shortterm skeletal muscle ischemia have been previously evaluated in experimental (7, 14, 16 -18, 20) and clinical (4, 8, 21, 30 ) studies, our previous (31) and present studies are the first to examine the effects of chronic skeletal muscle ischemia.
The findings of the present study indicate that chronic hindlimb ischemia 1) decreases infarct size after myocardial infarction without reperfusion (expressed either as a percentage of the total LV mass or as a percentage of the ischemic area at risk), 2) ameliorates LV systolic dysfunction after global myocardial ischemia followed by reperfusion, and 3) increases the density of noncapillary coronary arterioles and thereby 4) maintains coronary blood flow during regional myocardial ischemia.
Infarct size after permanent coronary ligation. Previous studies (4, 7, 8, 14, 16 -18, 20, 21, 30, 31) have demonstrated that ischemia of a skeletal muscle reduces infarct size after myocardial ischemia followed by reperfusion. The explanation for these findings is not well defined, and several suggestions have been put forward, such as inflammatory gene suppression (12) , modulation of ATP-sensitive K ϩ channels (32), nuclear factor-B-p105 or inducible nitric oxide synthase (13) , and free radical pathways (6) . A common denominator of these potential mechanisms is the reduction of reperfusion injury after I/R. However, previous studies have not provided a clear picture as to whether the beneficial effects of chronic skeletal muscle ischemia also apply to myocardial infarction without reperfusion. Should this be the case, additional mechanisms of cytoprotection are bound to be operative during myocardial ischemia, irrespective of subsequent reperfusion.
In the present study, we reported a marked decrease in the necrotic area by ϳ45% after permanent coronary ligation. Thus, our results demonstrate that chronic limb ischemia affords cytoprotection after myocardial ischemia with or without subsequent reperfusion and imply that additional mechanisms to the amelioration of reperfusion injury are operative. As such, neovascularization appears to be capable of maintaining coronary blood flow through functional collateral vessels, thereby limiting myocardial necrosis, as discussed in detail below.
LV dysfunction after I/R. An important finding in our study is the beneficial effects of chronic limb ischemia on LV function after global ischemia followed by reperfusion. Indexes of LV systolic function at the end of reperfusion, such as LV peak systolic pressure and LVDP as well as the first derivative of LV pressure, were improved in the limb ischemic group compared with the control group. During the ischemic phase, diastolic dysfunction was lower in hearts from limb ischemic animals, as indicated by the profile of ischemic contracture. Finally, diastolic function after reperfusion was also improved, although end-diastolic pressure remained elevated. Examined collectively, these findings indicate that the decrease in necrotic tissue after myocardial infarction is translated into the preservation of LV systolic and, to a lesser extent, diastolic function during I/R. The finding of the disproportionate improvement in LV diastolic function in our experiments is hard to explain but may be attributed to the lack of a significant effect of chronic skeletal muscle ischemia on reperfusion injury. Indeed, this process is likely mediated by excessive Ca 2ϩ influx during reperfusion (29) , resulting initially in diastolic dysfunction followed by cell death. Thus, the disparate improvement in diastolic (compared with systolic) dysfunction observed in our experiments reinforces our conclusion on the minor role of reperfusion injury amelioration as part of the explanation of the benefits observed after chronic hindlimb ischemia.
Preservation of coronary blood flow. We (31) have previously demonstrated that chronic limb ischemia, induced with a surgical protocol identical to that used in the present study, increases the number of noncapillary, nonlymphatic blood vessels in the normal rabbit heart. However, the functional significance of these vessels, in terms of the maintenance of coronary blood flow and LV function, was not examined in our previous study. Here, we report a significant decrease in coronary blood flow after left coronary artery ligation in control rats but preserved flow in rats subjected to chronic limb ischemia. These results indicate a functioning collateral circulation network between the right and left coronary arteries capable of maintaining coronary blood flow during regional ischemia under conditions of maximal vasodilatation (attained by the addition of adenosine in the perfusion solution). Thus, our present and previous findings indicate that neovascularization in the ventricular myocardium, secondary to chronic skeletal muscle ischemia, is a prominent mechanism for the decreased necrotic area after coronary artery ligation in the presence or absence of reperfusion.
Coronary vessel density. We found a marked increase in neovascularization in the ventricular myocardium after chronic limb ischemia, resulting in almost double coronary vessel density compared with control animals. These changes, observed mostly in small arterioles, confirm our previous findings (31) in the rabbit model and indicate that this process is not species specific.
During chronic limb ischemia, blood supply is maintained, which is mediated by the development of collateral circulation. The main stimulus that initiates arteriogenesis is the increased shear stress inside preexisting collateral vessels and small arteries proximal to a point of severe stenosis or total occlusion (10) . Neovascularization is supported by growth factors, chemokines, proteases, and inflammatory cells, which are excreted locally during ischemia, but they circulate and may act in remote tissues, such as in the ventricular myocardium (13) .
Previous research has tried to identify the stimuli for local or remote neovascularization process; in these studies, vascular endothelial growth factor, hypoxia inducible factor-1, and fibroblast growth factor have been proposed as the main stimuli for angiogenesis and capillary formation (3). However, angiogenesis is regulated by complex molecular mechanisms involving the participation of multiple factors. Recent studies (25, 26) on the interaction between skeletal muscle and the myocardium have implicated follistatin-like 1, an extracellular glycoprotein secreted by skeletal muscles in response to ischemic insult. Follistatin-like 1 was found to stimulate vascularization through its ability to activate Aktendothelial nitric oxide synthase signaling. In this study (26) , ischemic hindlimb surgery in the mouse model, with a protocol almost identical to our experiments, led to the induction of follistatin-like 1 in skeletal muscle and increased circulating levels of this protein. It has been proposed that skeletal muscle secrete factors, referred to as "myokines," that can influence the function of remote tissues, such as the intact ventricular myocardium (28) . These findings reinforce our hypothesis, namely, that chronic skeletal muscle ischemia increases the production of proangiogenic factors that circulate and may act in other vascular beds, such as the coronary circulation. Moreover, recent evidence has indicated that follistatin-like 1 has multiple actions, exerting not only proangiogenic actions but also cardioprotective actions, by exerting antiapoptotic actions in cardiomyocytes (24). 
